Pediatric emergency department visits for uncontrolled pain in postoperative adenotonsillectomy patients

Kathleen R Billings1,2, Renee C B Manworren3,4, Jennifer Lavin1,2

  • 1Division of Pediatric Otolaryngology-Head and Neck Surgery Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois.

Insights

Adenotonsillectomy (T&A) patients represent the largest group returning to the emergency department (ED) for postoperative pain. Opioid administration in the ED was linked to older children and insurance type, not demographics.

Area of Science:

  • Pediatric Emergency Medicine
  • Pain Management
  • Healthcare Informatics

Background:

  • Postoperative pain management after adenotonsillectomy (T&A) is a significant concern.
  • Understanding factors influencing emergency department (ED) returns and analgesic use is crucial for optimizing care.

Purpose of the Study:

  • To identify demographic variables associated with ED returns for postoperative pain after T&A.
  • To analyze analgesic administration, specifically opioids, in the ED for these patients.

Main Methods:

  • Analysis of the Pediatric Health Information System (PHIS) database.
  • Inclusion of data from 47 children's hospitals (2014-2015).
  • Examination of 2459 ED visits for acute postoperative pain, with a focus on 861 T&A patients.

Main Results:

  • T&A patients constituted the largest subgroup (35%) of ED returns for postoperative pain.
  • Opioid administration in the ED increased with the child's age (P = .01) and was higher for commercially insured patients.
  • Opioids were administered to 23.7% of patients, combined with non-opioids to 51%, and no pain medication to 5.9%.

Conclusions:

  • T&A patients are the primary demographic returning to the ED for postoperative pain.
  • Approximately 74.7% of returning patients received opioids (alone or combined).
  • ED opioid use was associated with older age and payer status, but not gender, race, surgical diagnosis, or ethnicity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
663
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.4K